Katherine Athayde Teixeira de Carvalho

Graduated in Medicine from the School of Medical Sciences of Minas Gerais (1984), Medical Residency in Pediatrics and Neurology, the USP Ribeirão Preto (1987) and titration by MEC in their areas of residence, Specialization in Biology, Pathology and Neuromuscular development: Université de Paris VII and Hospital Pitié Salpêtrière, State Doctorate in 1988-1991, Master of Neurology at the University of São Paulo (1994) and PhD in Biotechnological Processes by the Federal University of Paraná (2006). He is currently a Professor at the Graduate Biotechnology of Child and Adolescent Health, strict sense: Doctorate and Masters (note: 05 Capes) of the Small Colleges Prince and Researcher of Small Complex prince Unit Research Institute Pelé Little Prince-Search Health of Children and Adolescents; Invited Professor at the Graduate Biotechnological Processes in UFPR, sensu. He has experience in the area of ​​medicine, with emphasis on Neurology and Neuromuscular, and develops research in Cell Therapy area and Biotechnology in Regenerative Medicine, acting on the following topics: Myocardial Regeneration, Central Nervous System, particularly the spinal medulla, Parkinson, Muscular skeletal regeneration for Myopathies and trauma. Developed regeneration research is mainly based on the development of Experimental Animal Model for greater impact and prevalence of diseases: Myocardial Infarction, Trauma Spinal Cord, Parkinson, Amyotrophic lateral sclerosis, multiple sclerosis and Alzheimer's disease, epilepsy in mice stem cells from bone marrow: hematopoietic and mesenchymal, skeletal myoblasts, mesenchymal stem cells derived from adipose tissue. Develops basic research for improvement of insulation techniques, cultivation, expansion, new in vitro models for the reproduction of models of diseases, particularly neurodegenerative and cryopreservation of animal and human cells; adult stem cells of various origins: bone marrow, umbilical cord, milk, fat, as well as the development of biomaterials: amnion and placental cellulose. Acted in isolation from Human Stem Cells for two Multicenter in the field of Cardiology: Chagas cardiomyopathy and chronic ischemic, responsible Technique, in Curitiba (PR). Extended its activities in Biotechnology Research Projects Biocompatible Matrix and Nanotechnology applied to tissue regeneration: Myocardial, Central Nervous System, Skin and Bone Tissue for the development of New Therapies, participating in Nanobiotechnology Network and Capes for the development of new medicines . It operates in Editorials International as an editor and referee for journals indexed in PubMed. (Texto informado pelo autor)